A tax imposed by the Greek government on imported drugs and cosmetics has been declared by the European Commission to be in breach of European Union rules, and has ordered its abolition. The Commission ruled that the financing of the Greek National Organization of Pharmaceuticals by the import levy is incompatible with the common market, and should not be paid.
The tax was first introduced in 1983 to subsidize the Organization and its subsidiaries the National Industry of Pharmaceuticals and the State Deposit of Pharmaceuticals; the NIP and the SDP have since collapsed. The Commission then began an investigation of the aid scheme in 1992.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze